Skip to main content

DISFUNCION SINAPTICA Y RECAMBIO DE PROTEINAS EN NEURONAS CORTICALES Y CEREBELARES

PID2019-105530GB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Interfacing with the Brain: How Nanotechnology Can Contribute

  • Ahmed, Abdullah A. A.
  • Alegret, Nuria
  • Almeida, Bethany
  • Álvarez-Puebla, Ramón
  • Andrews, Anne M.
  • Ballerini, Laura
  • Barrios-Capuchino, Juan J.
  • Becker, Charline
  • Blick, Robert H.
  • Bonakdar, Shahin
  • Chakraborty, Indranath
  • Chen, Xiaodong
  • Cheon, Jinwoo
  • Chilla, Gerwin
  • Coelho Conceicao, Andre Luiz
  • Delehanty, James
  • Dulle, Martin
  • Efros, Alexander L.
  • Epple, Matthias
  • Fedyk, Mark
  • Feliu, Neus
  • Feng, Miao
  • Fernández-Chacón, Rafael
  • Fernández-Cuesta, Irene
  • Fertig, Niels
  • Förster, Stephan
  • Garrido, Jose A.
  • George, Michael
  • Guse, Andreas H.
  • Hampp, Norbert
  • Harberts, Jann
  • Han, Jili
  • Heekeren, Hauke R.
  • Hofmann, Ulrich G.
  • Holzapfel, Malte
  • Hosseinkazemi, Hessam
  • Huang, Yalan
  • Huber, Patrick
  • Hyeon, Taeghwan
  • Ingebrandt, Sven
  • Ienca, Marcello
  • Iske, Armin
  • Kang, Yanan
  • Kasieczka, Gregor
  • Kim, Dae-Hyeong
  • Kostarelos, Kostas
  • Lee, Jae-Hyun
  • Lin, Kai-Wei
  • Liu, Sijin
  • Liu, Xin
  • Liu, Yang
  • Lohr, Christian
  • Mailänder, Volker
  • Maffongelli, Laura
  • Megahed, Saad
  • Mews, Alf
  • Mutas, Marina
  • Nack, Leroy
  • Nakatsuka, Nako
  • Oertner, Thomas G.
  • Offenhäusser, Andreas
  • Oheim, Martin
  • Otange, Ben
  • Otto, Ferdinand
  • Patrono, Enrico
  • Peng, Bo
  • Picchiotti, Alessandra
  • Pierini, Filippo
  • Pötter-Nerger, Monika
  • Pozzi, Maria
  • Pralle, Arnd
  • Prato, Maurizio
  • Qi, Bing
  • Ramos-Cabrer, Pedro
  • Genger, Ute Resch
  • Ritter, Norbert
  • Rittner, Marten
  • Roy, Sathi
  • Santoro, Francesca
  • Schuck, Nicolas W
  • Schulz, Florian
  • Şeker, Erkin
  • Skiba, Marvin
  • Sosniok, Martin
  • Stephan, Holger
  • Wang, Ruixia
  • Wang, Ting
  • Wegner, K. David
  • Weiss, Paul S.
  • Xu, Ming
  • Yang, Chenxi
  • Zargarian, Seyed Shahrooz
  • Zeng, Yuan
  • Zhou, Yaofeng
  • Zhu, Dingcheng
  • Zierold, Robert
  • Parak, Wolfgang J.
Interfacing artificial devices with the human brain is the central goal of neurotechnology. Yet, our imaginations are often limited by currently available paradigms and technologies. Suggestions for brain-machine interfaces have changed over time, along with the available technology. Mechanical levers and cable winches were used to move parts of the brain during the mechanical age. Sophisticated electronic wiring and remote control have arisen during the electronic age, ultimately leading to plug-and-play computer interfaces. Nonetheless, our brains are so complex that these visions, until recently, largely remained unreachable dreams. The general problem, thus far, is that most of our technology is mechanically and/or electrically engineered, whereas the brain is a living, dynamic entity. As a result, these worlds are difficult to interface with one another. Nanotechnology, which encompasses engineered solid-state objects and integrated circuits, excels at small length scales of single to a few hundred nanometers and, thus, matches the sizes of biomolecules, biomolecular assemblies, and parts of cells. Consequently, we envision nanomaterials and nanotools as opportunities to interface with the brain in alternative ways. Here, we review the existing literature on the use of nanotechnology in brain-machine interfaces and look forward in discussing perspectives and limitations based on the authors' expertise across a range of complementary disciplines─from neuroscience, engineering, physics, and chemistry to biology and medicine, computer science and mathematics, and social science and jurisprudence. We focus on nanotechnology but also include information from related fields when useful and complementary., This work is supported by the Cluster of Excellence ‘Advanced Imaging of Matter’ EXC 2056 - project ID 390715994 (M.Skiba, W.J.P.) and the Research Training Group (Graduiertenkolleg) 2536 - project ID 408076438 (A.M., C.B., F.O., W.J.P.) of the Deutsche Forschungsgemeinschaft (DFG) and the Bundesministerium für Bildung und Forschung (BMBF) - project number 01DR19006 (L.N., W.J.P.) and 13GW0230A (U.G.H.). Several aspects have also been discussed in the framework of the Partnership for Innovation, Education and Research (PIER, PIER Plus). N.F. was funded by Fraunhofer Attract (Fraunhofer-Gesellschaft; Grant No. Attract 178-600040). A.A.A.A., S.B., I.C., and J.Harberts are grateful to the Alexander von Humboldt Foundation. A.A. further acknowledges funding by IIE-SRF Alliance. I.C. also thanks the Science & Engineering Research Board (SERB) (project id: SRG/2022/000135) for support. Y.H., Y.K., Y.L., B.Q., Y.K., Y.L., B.Q., Y.H., M.F., C.Y., B.P., J.Han, Y.Zeng, and Y.Zhou were funded by China Scholarship Council (CSC). H.H., S.M., and B.O. were supported by the German Academic Exchange Service (DAAD). B.A. acknowledges support from the Naval Research Laboratory and American Society for Engineering Education Postdoctoral Research Fellowship, as well as NSF CBET #2138587. J.J.B.-C. acknowledges support from CONACYT (México, doctoral scholarship number 862535). P.H. acknowledges support through the research initiative BlueMat: Water-Driven Materials, Hamburg and the Centre for Molecular Water Science CMWS, Hamburg. V.M. thanks the Carl Zeiss Foundation for support of the project InteReg and the Leibniz Science Campus NanoBrain. N.N. was supported by an ETH postdoctoral fellowship. M.O. acknowledges support from the French National Funding Agency (ANR), the Centre National de la Recherche Scientifique, and the EU. T.H. and D.-H.K. acknowledge the financial support by the Institute for Basic Science (IBS-R006-D1 and IBS-R006-A1). X.L. was supported by the Guangzhou Oversea Program. M.P. was funded by the project HeatNMof from European Union’s Horizon 2020 program. S.R. acknowledges funding from Department of Biotechnology, DBT – BioCARe Programme, India. E.Ş. acknowledges funding from National Institutes of Health (NIH) via NINDS/NIA R03-NS118156 and NCCIH R21-AT010933 and from the National Science Foundation via DMR-2003849. K.D.W. acknowledges the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 846764. U.R.G. received financial support by the German Research Council (DFG, grant RE 1203/38-1. SIREN). J.B.D. and A.L.E. acknowledge the financial support of the Office of Naval Research (ONR) through the Naval Research Laboratory Basic Research Program and the NRL Nanoscience Institute. S.S.Z. and F.P. acknowledge the First TEAM grant number POIR.04.04.00-00-5ED7/18-00, which has been conducted within the framework of the First TEAM programme of the Foundation for Polish Science (FNP) and cofinanced by the European Union under the European Regional development Fund. R.F.-C. acknowledges support from the Spanish Agencia Estatal de Investigación (PID2019-105530GB-I00, PID2022-138957NB-100, MICIU/AEI/10.13039/501100011033), CIBERNED (ISCIII), Junta de Andalucía (CUII, US-1381657), and European Regional Development Fund (ERDF). A.H.G. and C.L. received financial support by the DFG Collaborative Research Centre (SFB) 1328–project number 335447717. A.H.G. is also supported by the DFG Research Group Neuroflame (GU 360/22-1). M.E. acknowledges the financial support by the Bundesministerium für Bildung und Forschung (BMBF) within the project 3DOS (project number 161L0278A). A.M.A. is supported by the National Institute of Mental Health (grant #R61 MH135106). A.P. acknowledges funding from National Institutes of Health (NIMH #R01 MH111872 and #R01 MH094730). R.A.-P. was supported by the projects PID2020-120306RB-I00 (funded by MCIN/AEI/10.13039/501100011033), PDC2021-121787-I00 (funded by MCIN/AEI/10.13039/501100011033 and European Union Next Generation EU/PRTR), 2020SGR00166 (funded by Generalitat de Cataluña), and 2021PFR-URV-B2-02 (funded by Universitat Rovira i Virgili). N.W.S. acknowledges the support of the Excellence Strategy of the German Federal Government and the Länder and a Starting Grant from the European Union (ERC StG REPLAY-852669)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Neuronal lipofuscinosis caused by Kufs disease/CLN4 DNAJC5 mutations but not by a CSPα/DNAJC5 deficiency

  • López-Begines, Santiago
  • Borjini, Nozha
  • Lavado-Roldán, Ángela
  • Mesa-Cruz, Cristina
  • Mavillard, Fabiola
  • Wiersma, Vera I.
  • Rubio-Pastor, Fátima
  • Tumini, Emanuela
  • Paradela-Leal, Carmen
  • Chiclana-Valcárcel, María L.
  • Aguado, Carolina
  • Luján, Rafael
  • Scheper, Wiep
  • Nieto-González, J.
  • Fernández-Chacón, Rafael
Kufs disease/CLN4 is an autosomal dominant neurodegenerative disorder caused by unknown mechanisms through Leu115Arg and Leu116Δ mutations in the DNAJC5 gene that encodes the synaptic vesicle co-chaperone cysteine string protein α (CSPα/DNAJC5). To investigate the disease mechanisms in vivo, we generated three independent mouse lines overexpressing different versions of CSPα/DNAJC5 under the neuron-specific Thy1 promoter: wild-type (WT), Leu115Arg, and Leu116Δ. Mice expressing mutant Leu115Arg CSPα/DNAJC5 are viable but develop motor deficits. As described in patients with Kufs disease, we observed the pathological lipofuscinosis and intracellular structures resembling granular osmiophilic deposits (GRODs) in the mutant but not in the WT transgenic lines. Microglia engulf lipofuscin and lipofuscin-containing neurons. Notably, conventional or conditional knockout mice lacking CSPα/DNAJC5 did not exhibit any signs of increased lipofuscinosis or GRODs. Our novel mouse models provide a valuable tool to investigate the molecular mechanisms underlying Kufs disease/CLN4. DNAJC5 mutations cause neuronal lipofuscinosis through a cell-autonomous gain of a pathological function of CSPα/DNAJC5., This work was supported by Spanish Agencia Estatal de Investigación and Ministerio de Ciencia, Innovación y Universidades and European Regional Development Fund (ERDF), (MICIU/AEI/10.13039/501100011033, FEDER, UE): BFU2016-76050-P (R.F.-C.), PID2019-105530GB-I00 (R.F.-C.), PID2022-138957NBI00 (R.F.-C.), PID2021-125875OB-I00 (R.L.), BES-2011-046029 (Á.L.-R.), BES-2017-082324 (C.M.-C.), PRE2020/095166 (C.P.-L.), and FPU18/01700 (F.R.-P.); Andalusian Consejería de Universidad, Investigación e Innovación, CUII, P12-CTS-2232, P18FR-2144, CTS-600 (R.F.-C.); Andalusian Consejería de Salud y Consumo, RH-0064-2021 (N.B.); INVESTIGO Program funded by the European Union through the Recovery, Transformation, and Resilience Plan for Andalusia (M.L.C.-V.); Institute of Health Carlos III (ISCIII) and MICIU: FORTALECE (FORT23/00008) and CIBERNED (R.F.-C.); Junta de Comunidades de Castilla-La Mancha, SBPLY/21/180501/000064 (to R.L.); ZonmMW Memorabel/Alzheimer Nederland, no. 733050101 (W.S.)., Peer reviewed